TY - JOUR
T1 - Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis
AU - Cohen Tervaert, J. W.
AU - Goldschmeding, R.
AU - Elema, J. D.
AU - Van der Giessen, M.
AU - Huitema, M. G.
AU - Van der Hem, G. K.
AU - The, T. H.
AU - Von dem Borne Kr., A. E.G.
AU - Kallenberg, C. G.M.
N1 - Funding Information:
This study was supported by grants C 84.514 and C 85.552 from the Dutch Kidney Foundation. We acknowledge the help and cooperation of the patients, the referring physicians, our specialist colleagues and our house staff. Particular thanks are due to Dr. F.J. van der Woude (University Hospital, Leiden, The Netherlands) and Dr. P.C. Limburg for valuable discussion, Dr. C,T. Buiter for providing ear, nose and throat consul- tation on these patients, Dr. C.E. van der Schoot (CLB, Amsterdam) for providing the monoclonal antibody against myeloperoxidase, Dr. D.Y. Mason (Oxford, United Kingdom) for providing the monoclonal antibody against elastase, Dr. J.A. Kramps (University Hospital, Leiden, The Netherlands) for providing the rabbit anti-elastase used in this study, Dr. P.E. de Jong, Dr. W. van Luijk and Dr. W. Reitsma- Bierens for cooperation in obtaining clinical data, Dr. J Steensma and Dr. D.S. Postma for samples from tuberculosis and sarcoidosis pa- tients, Miss Coby van der Veen for technical assistance and Miss Kiki Bugter for typing the manuscript.
PY - 1990
Y1 - 1990
N2 - To investigate the possible association of crescentic glomurulonephritis (CGN) with autoantibodies to myeloid lysosomal enzymes, we tested sera from 35 consecutive patients with CGN without diagnostic immunohistochemical findings in their renal biopsy for the presence of antineutrophil cytoplasmic antibodies directed against a 29 kD antigen from azurophilic granules (29 kD-ANCA), against myeloperoxidase (MPO-ANCA) and against elastase (elastase-ANCA), using antigen-catching ELISAs with well-defined monoclonal antibodies. 29 kD-ANCA were present in the sera of all nine patients with CGN as part of biopsy-proven Wegener's granulomatosis (WG), of ten patients with CGN and clinically suspected WG, and of two patients with idiopathic CGN. Sera from the remaining patients with clinically suspected WG (N = 5) or idiopathic CGN (N = 6) were negative for 29 kD-ANCA, but invariably positive for MPO-ANCA. Neither of these antibodies could be detected in sera from patients with CGN of infectious origin (N = 3), different forms of CGN (N = 7), other renal lesions (N = 34), or normal controls (N = 52). None of the sera tested were positive for elastase-ANCA. Our results indicate that both vasculitis-associated CGN and idiopathic CGN are associated with autoantibodies against myeloid lysosomal enzymes. This finding places these disorders within one spectrum of diseases.
AB - To investigate the possible association of crescentic glomurulonephritis (CGN) with autoantibodies to myeloid lysosomal enzymes, we tested sera from 35 consecutive patients with CGN without diagnostic immunohistochemical findings in their renal biopsy for the presence of antineutrophil cytoplasmic antibodies directed against a 29 kD antigen from azurophilic granules (29 kD-ANCA), against myeloperoxidase (MPO-ANCA) and against elastase (elastase-ANCA), using antigen-catching ELISAs with well-defined monoclonal antibodies. 29 kD-ANCA were present in the sera of all nine patients with CGN as part of biopsy-proven Wegener's granulomatosis (WG), of ten patients with CGN and clinically suspected WG, and of two patients with idiopathic CGN. Sera from the remaining patients with clinically suspected WG (N = 5) or idiopathic CGN (N = 6) were negative for 29 kD-ANCA, but invariably positive for MPO-ANCA. Neither of these antibodies could be detected in sera from patients with CGN of infectious origin (N = 3), different forms of CGN (N = 7), other renal lesions (N = 34), or normal controls (N = 52). None of the sera tested were positive for elastase-ANCA. Our results indicate that both vasculitis-associated CGN and idiopathic CGN are associated with autoantibodies against myeloid lysosomal enzymes. This finding places these disorders within one spectrum of diseases.
UR - https://www.scopus.com/pages/publications/0025063931
U2 - 10.1038/ki.1990.48
DO - 10.1038/ki.1990.48
M3 - Article
C2 - 2155342
AN - SCOPUS:0025063931
SN - 0085-2538
VL - 37
SP - 799
EP - 806
JO - Kidney International
JF - Kidney International
IS - 2
ER -